Literature DB >> 16322470

Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation.

Junwon Lee1, Kabsun Kim, Jung Ha Kim, Hye Mi Jin, Han Kyung Choi, Seoung-Hoon Lee, Hyun Kook, Kyung Keun Kim, Yoshifumi Yokota, Soo Young Lee, Yongwon Choi, Nacksung Kim.   

Abstract

Tumor necrosis factor (TNF)-related activation-induced cytokine (TRANCE) induces osteoclast formation from monocyte/macrophage lineage cells via various transcription factors, including the Mi transcription factor (Mitf). Here, we show that inhibitors of differentiation/DNA binding (Ids), helix-loop-helix (HLH) transcription factors, negatively regulate TRANCE-induced osteoclast differentiation. Expression levels of Id1, Id2, and Id3 genes are significantly reduced by TRANCE during osteoclastogenesis. Interestingly, overexpression of the 3 Id genes in bone marrow-derived monocyte/macrophage lineage cells (BMMs) inhibits the formation of tartrate-resistant acid phosphatase (TRAP)-positive multinuclear osteoclasts, but it does not alter the ability of BMMs to either phagocytose or differentiate into dendritic cells (DCs). Overexpression of Id2 in BMMs attenuates the gene induction of nuclear factor of activated T cells c1 (NFATc1) and osteoclast-associated receptor (OSCAR) during TRANCE-mediated osteoclastogenesis. Furthermore, Id proteins interact with Mitf, a basic HLH (bHLH) transcription factor, and inhibit its transactivation of OSCAR, which is a costimulatory receptor expressed by osteoclast precursors, by attenuating the DNA binding ability of Mitf to the E-box site of the OSCAR promoter. Taken together, our results reveal both a new facet of negative regulation, mediated by Id proteins, as well as the mechanism whereby TRANCE signaling overcomes it, allowing osteoclastogenesis to proceed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16322470      PMCID: PMC1895380          DOI: 10.1182/blood-2005-07-2798

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  43 in total

1.  Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice.

Authors:  K N Weilbaecher; G Motyckova; W E Huber; C M Takemoto; T J Hemesath; Y Xu; C L Hershey; N R Dowland; A G Wells; D E Fisher
Journal:  Mol Cell       Date:  2001-10       Impact factor: 17.970

2.  Genetic and physical interactions between Microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation.

Authors:  A Luchin; S Suchting; T Merson; T J Rosol; D A Hume; A I Cassady; M C Ostrowski
Journal:  J Biol Chem       Date:  2001-07-31       Impact factor: 5.157

Review 3.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

4.  The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts.

Authors:  A Luchin; G Purdom; K Murphy; M Y Clark; N Angel; A I Cassady; D A Hume; M C Ostrowski
Journal:  J Bone Miner Res       Date:  2000-03       Impact factor: 6.741

5.  Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family.

Authors:  G Motyckova; K N Weilbaecher; M Horstmann; D J Rieman; D Z Fisher; D E Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

6.  Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis.

Authors:  Kabsun Kim; Jung Ha Kim; Junwon Lee; Hye-Mi Jin; Seoung-Hoon Lee; David E Fisher; Hyun Kook; Kyung Keun Kim; Yongwon Choi; Nacksung Kim
Journal:  J Biol Chem       Date:  2005-08-18       Impact factor: 5.157

7.  The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli.

Authors:  K Inaba; S Turley; T Iyoda; F Yamaide; S Shimoyama; C Reis e Sousa; R N Germain; I Mellman; R M Steinman
Journal:  J Exp Med       Date:  2000-03-20       Impact factor: 14.307

8.  A novel member of the leukocyte receptor complex regulates osteoclast differentiation.

Authors:  Nacksung Kim; Masamichi Takami; Jaerang Rho; Regis Josien; Yongwon Choi
Journal:  J Exp Med       Date:  2002-01-21       Impact factor: 14.307

9.  Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors.

Authors:  F Arai; T Miyamoto; O Ohneda; T Inada; T Sudo; K Brasel; T Miyata; D M Anderson; T Suda
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

Review 10.  ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis.

Authors:  J D Norton
Journal:  J Cell Sci       Date:  2000-11       Impact factor: 5.285

View more
  44 in total

1.  The transmembrane adaptor protein, linker for activation of T cells (LAT), regulates RANKL-induced osteoclast differentiation.

Authors:  Kabsun Kim; Jung Ha Kim; Jang Bae Moon; Jongwon Lee; Han Bok Kwak; Yong-Wook Park; Nacksung Kim
Journal:  Mol Cells       Date:  2012-02-28       Impact factor: 5.034

Review 2.  Osteoclastogenesis and arthritis.

Authors:  Nicola Maruotti; Maria Grano; Silvia Colucci; Francesca d'Onofrio; Francesco Paolo Cantatore
Journal:  Clin Exp Med       Date:  2010-11-11       Impact factor: 3.984

3.  The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-κB ligand (RANKL)-induced osteoclast differentiation.

Authors:  Masakazu Kogawa; Koji Hisatake; Gerald J Atkins; David M Findlay; Yuichiro Enoki; Tsuyoshi Sato; Peter C Gray; Yukiko Kanesaki-Yatsuka; Paul H Anderson; Seiki Wada; Naoki Kato; Aya Fukuda; Shigehiro Katayama; Masafumi Tsujimoto; Tetsuya Yoda; Tatsuo Suda; Yasushi Okazaki; Masahito Matsumoto
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

4.  Involvement of PRIP, phospholipase C-related, but catalytically inactive protein, in bone formation.

Authors:  Koshiro Tsutsumi; Miho Matsuda; Miho Kotani; Akiko Mizokami; Ayako Murakami; Ichiro Takahashi; Yoshihiro Terada; Takashi Kanematsu; Kiyoko Fukami; Tadaomi Takenawa; Eijiro Jimi; Masato Hirata
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

Review 5.  Transcription factors in the control of dendritic cell life cycle.

Authors:  Arpita S Bharadwaj; Devendra K Agrawal
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

6.  Cell-nonautonomous function of Id1 in the hematopoietic progenitor cell niche.

Authors:  Hyung Chan Suh; Ming Ji; John Gooya; Michael Lee; Kimberly D Klarmann; Jonathan R Keller
Journal:  Blood       Date:  2009-05-28       Impact factor: 22.113

7.  Identification of LRRc17 as a negative regulator of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclast differentiation.

Authors:  Taesoo Kim; Kabsun Kim; Seoung Hoon Lee; Hong-Seob So; Junwon Lee; Nacksung Kim; Yongwon Choi
Journal:  J Biol Chem       Date:  2009-03-31       Impact factor: 5.157

8.  The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis.

Authors:  Yoshiteru Miyauchi; Ken Ninomiya; Hiroya Miyamoto; Akemi Sakamoto; Ryotaro Iwasaki; Hiroko Hoshi; Kana Miyamoto; Wu Hao; Shigeyuki Yoshida; Hideo Morioka; Kazuhiro Chiba; Shigeaki Kato; Takeshi Tokuhisa; Mitinori Saitou; Yoshiaki Toyama; Toshio Suda; Takeshi Miyamoto
Journal:  J Exp Med       Date:  2010-04-05       Impact factor: 14.307

9.  Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone.

Authors:  L Endo-Munoz; A Cumming; S Sommerville; I Dickinson; N A Saunders
Journal:  Br J Cancer       Date:  2010-06-15       Impact factor: 7.640

10.  Id1 represses osteoclast-dependent transcription and affects bone formation and hematopoiesis.

Authors:  April S Chan; Kristian K Jensen; Dimitris Skokos; Stephen Doty; Hannah K Lederman; Rosandra N Kaplan; Shahin Rafii; Stefano Rivella; David Lyden
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.